Global Exchange fair trade store press room search
Programs in the Americas
get involved  
travel with reality tours  
update  
travel with reality tours  
regions  
Africa   
Americas   
Argentina   
Bolivia   
Brazil   
Colombia   
Costa Rica   
Cuba   
Ecuador   
Guatemala   
Haiti   
Honduras   
Jamaica   
Mexico   
Nicaragua   
Peru   
United States   
Venezuela   
Asia   
Middle East & Central Asia   
Europe   
What's New  

Journal editors disavow
article on biotech corn

Washington Post
April 4, 2002
By Marc Kaufman

The science journal Nature has concluded that a controversial article it published last year on the discovery of genetically engineered corn growing in Mexico was not well researched enough and should not have been published.

In a highly unusual "editorial note" in this week's edition of the journal, the editors said that based on criticisms of the article and assessments by outside referees, "Nature has concluded that the evidence available is not sufficient to justify the publication of the original paper."

That article had reported that corn from the southern state of Oaxaca contained genetically modified material, although Mexico has prohibited all engineered corn since 1998. The finding was especially important because corn originated in the southern valley of Mexico and Central America and the region remains the international center for corn diversity.

The initial study also offered evidence that the genes spliced into corn plants were unstable, a finding that would challenge a basic assumption about the workings of agricultural biotechnology.

The editor's note does not distinguish between the two aspects of the study, by David Quist and Ignacio Chapela at the University of California at Berkeley. But the two authors, a graduate student and a professor, said they stand by their first finding and believe they were on the right track with their second, although they may have misinterpreted some readings.

"None of the criticism put forward challenges our main statement, that there is corn growing in Mexico with genetically engineered material," Chapela said.

The initial study had been embraced by anti-biotechnology activists, who said it confirmed worries that the technology was spreading in uncontrolled and unapproved ways. But Nature's near-retraction of the article was welcomed by advocates for the technology.

"We believe that Nature erred in publishing the article to begin with, and it seems they came to the same unavoidable conclusion," said Val Giddings of the Biotechnology Industry Organization. "The authors made mistakes that first-year grad students learn to avoid, which further demonstrates that their commitment was not to data and science but to a religious commitment to an [anti-biotechnology] dogma."

Nick Kaplinsky, also a professor at Berkeley, wrote one of the criticisms of the Mexican corn study that are running in today's issue of Nature. He said he was especially drawn to the conclusion by Quist and Chapela that transgenes were "jumping around the genome" of Mexican corn, a conclusion that he said "would have changed some basic assumptions about biotechnology, if correct."

Kaplinsky said his review of the work showed basic errors in methodology that made the conclusion inappropriate. But he said that on the first question of whether genetically modified corn is growing in Mexico, "I think at some point soon, someone will come up with good scientific evidence that it is growing all over the country."

Nature is among the most respected of scientific journals, and its articles are aggressively peer-reviewed. A spokesperson said the editorial note saying the initial study should not have been published was "unprecedented" in recent times. The journal also included some new research from Quist and Chapela on Mexican corn alongside the note, and said it wanted to "allow our readers to judge the science for themselves."

Chapela said yesterday that he believed the effort to undermine the Mexican corn study was the work of biotechnology advocates, some of whom had personal reasons for attacking him. Chapela said that he led a successful movement at Berkeley several years ago to turn down a large grant from Novartis, a major biotechnology company, and that some Berkeley colleagues were still angry about that. Kaplinsky said their interest was to expose flawed science.


 Become a Member
 Get our eNewsletter

Printer-friendly version
Email to a friend

This page last updated July 09, 2007
Global Exchange | Search | Fair Trade Store | About Us | Contact Us
Become a Member | Get our eNewsletter | Take Action Now
Get Involved | What's New | Travel with Reality Tours
The Global Economy | War, Peace & Democracy | Programs by Region
© Global Exchange 2007
2017 Mission Street, 2nd Floor - San Francisco, CA 94110
t: 415.255.7296 f: 415.255.7498